Cargando…
Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
Autor principal: | Vansteenkiste, Johan F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190227/ https://www.ncbi.nlm.nih.gov/pubmed/30345082 http://dx.doi.org/10.1136/esmoopen-2018-000429 |
Ejemplares similares
-
Immunotherapy in lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018) -
Tumor evolution in non-small-cell lung cancer
por: Parry, Marina
Publicado: (2018) -
Questions asked in the everyday practice: immune checkpoint inhibitors
por: Haanen, John B A G
Publicado: (2018) -
Highlights in lung cancer in 2019
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020) -
ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
por: Punie, K., et al.
Publicado: (2020)